Kawasaki Disease (KD) is an acute, self-limited systemic vasculitis that affects the middle and small arteries, especially the coronary arteries. The incidence of KD is currently on the rise, with about 15 to 25 percent of children without systemic treatment, eventually developing coronary artery damage, Becoming the most common cause of child-acquired heart disease in the developed countries. At present, stem cell therapy for Kawasaki Disease in mice model has made important progress. This article reviews stem cell treatment of coronary artery lesion of Kawasaki Disease
